Bayesian Network for Pancreatic Cancer Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing pancreatic cancer, particularly using CA 19-9 cancer markers, face challenges with low sensitivity and high false-positive rates, making early and accurate diagnosis difficult due to the lack of objective criteria.
Innovation Solution
An artificial intelligence-based Bayesian network method that generates a statistical report from medical information, constructs a conditional probability table, and applies Bayesian conditional probability to calculate the likelihood of pancreatic cancer based on symptoms such as abdominal pain, nausea, weight loss, and CA 19-9 marker status, thereby improving diagnostic accuracy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If CA 19-9 cancer marker test is used for pancreatic cancer diagnosis, then the procedure is simple and cost-effective, but the sensitivity is low and false-positive rate is high
Solution Approach 1:
The patent combines multiple diagnostic parameters (CA 19-9 marker levels, abdominal pain, nausea/vomiting, weight loss, jaundice, diabetes history, smoking status, and family history) into a unified Bayesian network diagnostic system. This integration allows the system to leverage the simplicity of the CA 19-9 test while compensating for its low sensitivity through combined analysis with other clinical parameters, thereby improving overall diagnostic accuracy without significantly increasing procedural complexity.
Solution Approach 2:
The patent creates a composite diagnostic approach by combining quantitative marker data (CA 19-9 levels) with qualitative clinical symptoms and patient history. This composite diagnostic model functions similarly to composite materials, where multiple components with different strengths are combined to create a system that overcomes the weaknesses of individual components, achieving both simplicity and accuracy.
2Measurement precision
If multiple diagnostic parameters are integrated using Bayesian network, then diagnostic accuracy is improved, but computational complexity increases
Solution Approach 1:
The patent transforms complex multi-parameter diagnostic data into standardized probability values through the Bayesian network framework. By converting diverse clinical parameters (symptoms, marker levels, history) into unified probability representations and using conditional probability tables, the system simplifies the computational process while maintaining high diagnostic accuracy. This parameter transformation approach allows complex integrated analysis without proportionally increasing computational burden.
3Loss of time
If early screening is performed for pancreatic cancer, then early diagnosis opportunity is increased, but false-positive results lead to unnecessary concern and further invasive testing
Solution Approach 1:
The Bayesian network diagnostic system incorporates feedback mechanisms where the probability of pancreatic cancer is dynamically updated based on the combination of multiple parameters. This feedback approach allows the system to distinguish between true positive cases and false positives by continuously refining the diagnostic probability based on the pattern and combination of symptoms and markers, rather than relying on single-parameter thresholds that generate false alarms.
Data Source
AI summary
The present invention provides a method of providing information necessary for diagnosing pancreatic cancer using an artificial intelligence-based Bayesian network, comprising: generating a statistical report by learning medical information of a pancreatic cancer patient; constructing a conditional probability table using statistics for each symptom of an actual pancreatic cancer patient; constructing a Bayesian network using the conditional probability table constructed using the statistics for each symptom; applying a Bayesian conditional probability to the Bayesian network; and deriving a probability of getting pancreatic cancer when there is a specific symptom from the pancreatic cancer patient, wherein medical information on pancreatic cancer patients may be statistical data obtained through artificial intelligence or machine learning.